Pulmonary disposition of lomefloxacin in patients with acute exacerbation of chronic obstructive pulmonary disease: A multiple-dose study

Journal of Chemotherapy

Volumn 13, Issue 4, 2001, Pages 407-412

  Cazzola, M ^a   Matera, M G ^a   Tufano, M A ^a   Catalanotti, P ^a   Polverino, M ^a   Cantoni, V ^a   Fici, F ^a   Sarlo, F ^a   Rossi, F ^a  

^a NONE   (Italy)

Author keywords

Acute exacerbations of chronic bronchitis; Difluoroquinolone; Lomefloxacin; Pulmonary penetration; Quinolone

Indexed keywords

LOMEFLOXACIN; PLACEBO; QUINOLONE DERIVATIVE;

ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DISPOSITION; DRUG HALF LIFE; DRUG PENETRATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG LAVAGE; MALE; STEADY STATE;

EID: 0034896681     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.4.407     Document Type: Article

References (27)

1. In vitro activity of lomefloxacin (SC-47111, NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones
2. Pharmacokinetics and tissue penetration of orally administered lomefloxacin
3. Concentrations of oral lomefloxacin in serum and bronchial mucosa
4. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration
5. Pulmonary disposition of antimicrobial agents: In vivo observations and clinical relevance
6. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
7. Examination of sputum cells
8. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution
9. Pulmonary disposition of antimicrobial agents: Methodological considerations
10. Lomefloxacin: A review of this antimicrobial activity, pharmacokinetic properties and therapeutic use
11. Bacterial infection in chronic obstructive pulmonary disease
12. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis
13. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: An Italian multicenter study
14. Comparison of the safety and efficacy of lomefloxacin and amoxicillin in the treatment of acute exacerbations of chronic bronchitis: Results from a Latin American multicenter study
15. A multinational study of lomefloxacin vs. amoxicillin in treatment of acute exacerbations of chronic bronchitis
16. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: Results of multinational studies
17. Antibiotic penetration into the respiratory tract - A basis for rational therapy
18. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia: Relevance for drug efficacy
19. Overview of experience with ofloxacin in respiratory tract infections
20. A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses
21. New concepts in the pulmonary disposition of antibiotics
22. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes
23. The site concentrations of antimicrobial agents in lungs
24. Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage
25. Use of fluoroquinolones in lower respiratory tract infections (LRTI)
26. The penetration of ofloxacin into bronchial secretions
27. Clinical, microbiological and pharmacokinetic studies of ofloxacin in acute purulent exacerbations of chronic respiratory disease